A major advance in cancer investigation is arising with the use of mini-antibodies to re-engage mutated p53. This essential cancer inhibitor protein is frequently lost in several kinds of tumors, causing uncontrolled https://tealbookmarks.com/story21917418/nanobodies-revive-the-p53-protein-the-new-pathway-for-malignant-treatment